ID2 and chronic myelogenous leukemia, BCR-ABL1 positive: showed that mice transplanted with Id2-/- fetal liver cells develop leukocytosis after 6 months that resembles a myeloproliferative disorder, and that over expression of ID2 delays the onset BCR-ABL-induced CML in vivo (121).